Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) soared 40 percent week-on-week, with the company also experiencing a ...

We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals stock reached a key performance benchmark, with its Relative Strength (RS) Rating rising into the ...

Answering SPJA queries under differential privacy (DP), including graph-pattern counting under node-DP as an important ...

CompanyOverview|NASDAQ:RXRX] Recursion Pharmaceuticals' (NASDAQ: RXRX) stock price has seen a dramatic increase, not due to company-specific news or drug announcements, but rather due to actions taken ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Abstract: A new algorithm, the RSEM (Recursive simultaneous equations model) algorithm, is presented for causal structure learning under the LSEM (Linear structural equations model). The algorithm ...

A Montana judge on Wednesday struck down a state law defining sex in binary terms, finding that the law violated the Montana Constitution’s guarantees of equal protection and privacy. Judge Leslie ...

Definition: The issuing company fixes a particular date when the investor must own shares in order to be eligible to participate in corporate events like receiving dividend, bonus shares etc. This is ...